NASDAQ:BBI
Delisted

Brickell Biotech Stock Signals

etoro logo Buy BBI
*Your capital is at risk
$1.94
+0 (+0%)
At Close: Feb 07, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Brickell Biotech Inc.

General

Signal Type Signal Value Data
Score 0.000 96 days ( -5.43 %
Last Price $1.94 0 %
Performance History
7 Days
$1.94 $1.94
0%
30 Days
$1.94 $1.94
0%
12 Mos
$0.260 $1.94
646.15%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $1.94 - $1.94
Trend - 3 mos 1.02 % High Width: 11.60 %
Pred. range - 3 mos $1.77 - $1.97 Low -8.89 % - 1.68 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Feb 06, 2023 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 17, 2022 - 55 days
Short/Long MA 3 mos Sell Medium Nov 17, 2022 - 55 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.02
Signal Type Signal Value Importance Data
Trend - 12 mos 78.61 % Very High Width: 1,380.32 %
Pred. range - 12 mos $0.654 - $9.68 High -66.28 % - 399.10 %
Short MA 12 mos Buy Very High Oct 03, 2022 - 88 days
Long MA 12 mos Buy Very High Jan 30, 2023 - 7 days
Short/Long MA 12 mos Buy Very High Jan 30, 2023 - 7 days
Pivot Long Sell Low Feb 06, 2023 - 2 days
RSI Long Pivot Signal Buy Low Oct 11, 2022 - 82 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT BRICKELL BIOTECH INC.
Brickell Biotech
Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammato...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
7.87% Jun 12
DHI
$146.71
3.93% Jun 10
PHM
$118.49
2.86% Jun 10
EAT
$140.46
13.06% Jun 05
TPR
$140.47
3.84% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE